Trastuzumab Injection

This product is suitable for HER2-positive metastatic breast cancer: as a single drug treatment for metastatic breast cancer that has received one or more chemotherapy regimens; combined with paclitaxel or docetaxel for patients with metastatic breast cancer who have not received chemotherapy.
Adjuvant therapy for breast cancer:
This product is suitable for adjuvant treatment of HER2-positive breast cancer after surgery, adjuvant chemotherapy containing anthracyclines, and radiotherapy (if applicable).
Metastatic gastric cancer:
This product combined with capecitabine or 5-fluorouracil and cisplatin is suitable for patients with HER2-positive metastatic gastric adenocarcinoma or gastroesophageal junction adenocarcinoma who have not received previous treatment for metastatic disease.